Advertisement
Screener

ATOSSA THERAPEUTICS, INC. (ATOS) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

ATOSSA THERAPEUTICS, INC. Amortization of Intangible Assets

ATOSSA THERAPEUTICS, INC. (ATOS) reported Amortization of Intangible Assets of $27.60 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2021-03-31

  • ATOSSA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2016-09-30 was $0.00.
  • ATOSSA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2020 was $27.60K, a 10.39% decline from fiscal 2019.
  • ATOSSA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2019 was $30.80K, a 2.67% increase from fiscal 2018.
  • ATOSSA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2018 was $30.00K, a 70.88% decline from fiscal 2017.
  • ATOSSA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2017 was $103.04K.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 monthAmortization of Intangible Assets 12 month as first filed
2020-12-31$27.60K
10-K · filed 2021-03-31
2019-12-31$30.80K
10-K · filed 2021-03-31
$31.00K
10-K · filed 2020-03-26
2018-12-31$30.00K
10-K · filed 2020-03-26
$29.81K
10-K · filed 2019-03-28
2017-12-31$103.04K
10-K · filed 2019-03-28
2016-09-30$0.00
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21
$36.67K
10-Q/A · filed 2017-03-21
2016-06-30$36.67K
10-Q/A · filed 2017-03-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Rocket One Inc. (RKTO)United States$0.019B
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
NextCure, Inc. (NXTC)United States$0.024B-0.15
Biofrontera Inc. (BFRI)United States$0.018B-2.13